Trump Rx (2/16/2026)

Direct-to-consumer prescription platforms are operating by connecting patients directly with manufacturers, bypassing traditional insurance structures and pharmacy benefit managers. Removing intermediaries can help reduce costs for certain medications, while also noting trade-offs such as cash-only payment models that do not apply toward insurance deductibles. SHARx’s broader mission is to improve prescription access and affordability through more transparent pricing structures.

"I don’t think there is a healthcare mission more critical than what SHARx is doing. When less than 5% of the population is incurring nearly 90% of the drug spend, it is time for us all to come together” - Mike Kelly

Source